42例肺诺卡菌病患者的临床特征及其病原菌耐药性
作者:
作者单位:

1.河南省胸科医院检验科;2.河南省胸科医院呼吸与危重症六病区;3.河南省人民医院检验科

作者简介:

通讯作者:

王伟  E-mail: jyk2785@163.com

中图分类号:

R519.1

基金项目:

河南省医学科技攻关计划联合共建项目(LHGJ2018020563)


Clinical characteristics and antimicrobial resistance of pathogens of 42 patients with pulmonary nocardiasis
Author:
Affiliation:

1.Department of Laboratory Medicine, Henan Provincial Chest Hospital, Zhengzhou 450003, China;2.Department of Respiratory and Criti- cal Care Medicine-Ward Six, Henan Provincial Chest Hospital, Zhengzhou 450003, China;3.Department of Laboratory Medicine, Henan Provincial People's Hospital, Zhengzhou 450003, China

Fund Project:

  • 摘要
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 文章评论
    摘要:

    目的 了解肺诺卡菌病的临床特点,分析诺卡菌的耐药性,为临床规范诊疗提供依据。 方法 收集2016—2021年河南省胸科医院临床诊断为肺诺卡菌病患者的病历资料,采用基质辅助激光解吸飞行时间质谱仪(MALDI-TOF MS)和分子生物学技术对分离菌株进行鉴定,并采用微量肉汤稀释法(MIC)进行药敏试验,分析患者的临床特点及药敏结果。 结果 共有42例诺卡菌感染患者,男性24例,女性18例。88.1%的患者合并有基础疾病,包括支气管扩张、糖尿病、慢性阻塞性肺疾病(COPD)等。42例患者中有50.0%合并其他病原体感染,其中合并曲霉菌、结核分枝杆菌感染各5例。41例进行肺部CT检查的患者影像学表现以结节影(78.0%)和斑片影(58.5%)为主,24.4%的患者伴有胸腔积液。实验室检查中,中性粒细胞百分比升高者占66.7%,75.0%的患者出现C反应蛋白升高和血沉增快,低蛋白血症患者占54.8%。肺诺卡病患者分离最多的为盖尔森基兴诺卡菌(11株),不同诺卡菌种药敏试验结果不同,但所有分离株对复方磺胺甲唑、阿米卡星、利奈唑胺均敏感。大多数患者采用基于以磺胺类药物为主的联合治疗方案,83.3%(35例)患者好转出院。 结论 肺诺卡菌病易发生于支气管扩张及免疫力低下患者,临床特点无明显特异性,且易合并曲霉菌和结核菌等其他病原体感染,实验室应对诺卡菌进行药敏试验,以便为临床精准治疗提供依据。

    Abstract:

    Objective To understand the clinical characteristics of pulmonary nocardiosis, analyze antimicrobial resistance of Nocardia, and provide basis for clinical standard diagnosis and treatment. Methods Medical records of patients clinically diagnosed as pulmonary nocardiosis in Henan Chest Hospital from 2016 to 2021 were collected, the isolated strains were identified by matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and molecular biological technology, antimicrobial susceptibility testing was performed by micro-broth dilution, clinical characteristics and antimicrobial susceptibility testing results of patients were analyzed. Results There were 42 patients with Nocardia infection, including 24 males and 18 females. 88.1% of the patients had underlying diseases, including bronchiectasis, diabetes, chronic obstructive pulmonary disease, etc. 50.0% of the 42 patients were complicated with other pathogens, 5 of whom were with Aspergillus and 5 with Mycobacterium tuberculosis infection. The imaging findings of pulmonary CT examination of 41 patients were mainly nodular shadow (78.0%) and patchy shadow (58.5%), and 24.4% of patients were accompanied by pleural effusion. In the laboratory examination, 66.7% of the patients had an increase in the percentage of neutrophils, 75.0% of the patients had an increase in C-reactive protein and erythrocyte sedimentation rate, and 54.8% of the patients had hypoproteinemia. Nocardia cyriacigeorgica was the main strain (11 strains) isolated from patients with pulmonary nocardiosis, antimicrobial susceptibility testing results of different Nocardia strains were different, but all strains were susceptible to compound sulfamethoxazole, amikacin and linezolid. Most patients adopted the combined treatment based on sulfonamides, and 83.3% (35 cases) of patients improved and were discharged. Conclusion Pulmonary nocardiosis is easy to occur in patients with bronchiectasis and low immunity, its clinical characteristics are not obviously specific, and is easy to be complicated with infection of Aspergillus, tubercle bacillus and other pathogens, labor-atory should perform antimicrobial susceptibility testing of Nocardia, provide basis for clinical precision treatment.

    参考文献
    相似文献
引用本文

韩云港,韩俊垒,陈会会,等.42例肺诺卡菌病患者的临床特征及其病原菌耐药性[J]. 中国感染控制杂志,2022,(7):668-674. DOI:10.12138/j. issn.1671-9638.20222703.
Yun-gang HAN, Jun-lei HAN, Hui-hui CHEN, et al. Clinical characteristics and antimicrobial resistance of pathogens of 42 patients with pulmonary nocardiasis[J]. Chin J Infect Control, 2022,(7):668-674. DOI:10.12138/j. issn.1671-9638.20222703.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-03-30
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-08-01
  • 出版日期: